{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T12:44:49Z","timestamp":1769690689692,"version":"3.49.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T00:00:00Z","timestamp":1553558400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Strahlenther Onkol"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s00066-019-01458-1","type":"journal-article","created":{"date-parts":[[2019,3,26]],"date-time":"2019-03-26T15:02:47Z","timestamp":1553612567000},"page":"668-676","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Tomotherapy in malignant mesothelioma: a\u00a0planning study to establish dose constraints","Tomotherapie bei malignem Pleuramesotheliom: eine Planungsstudie zur Etablierung von Dosisbeschr\u00e4nkungen"],"prefix":"10.1007","volume":"195","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7397-8569","authenticated-orcid":false,"given":"Christina","family":"Leitzen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timo","family":"Wilhelm-Buchstab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabina","family":"Stumpf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Heimann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Koch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Schmeel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birgit","family":"Simon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susanne","family":"Vornholt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Garbe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fred","family":"R\u00f6hner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix","family":"Schoroth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans Heinz","family":"Schild","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heinrich","family":"Sch\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"M\u00fcdder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,26]]},"reference":[{"issue":"9","key":"1458_CR1","doi-asserted-by":"publisher","first-page":"e532","DOI":"10.1016\/S1470-2045(17)30459-X","volume":"18","author":"M Perrot","year":"2017","unstructured":"Perrot M, Wu L, Wu M, Cho BCJ (2017) Radiotherapy for the treatment of malignant pleural mesothelioma. Lancet Oncol 18(9):e532\u2013e542","journal-title":"Lancet Oncol"},{"issue":"1","key":"1458_CR2","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.ijrobp.2014.08.343","volume":"91","author":"WW Chance","year":"2015","unstructured":"Chance WW, Rice DC, Allen PK (2015) Hemithoracic intensity modulated radiation therapy after pleurectomy\/decortication for malignant pleural mesothelioma: toxicity, patterns of failure, and a\u00a0matched survival analysis. Int J Radiat Oncol Biol Phys 91(1):149\u2013156","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"1458_CR3","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.jtho.2017.02.026","volume":"12","author":"F Shaikh","year":"2017","unstructured":"Shaikh F, Zauderer MG, von Reibnitz D et al (2017) Improved outcomes with modern lung-sparing trimodality therapy in patients with malignant pleural mesothelioma. J\u00a0Thorac Oncol 12(6):993\u20131000","journal-title":"J Thorac Oncol"},{"issue":"5","key":"1458_CR4","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s00066-018-1266-6","volume":"194","author":"C Nieder","year":"2018","unstructured":"Nieder C, Gaspar LE, Ruysscher D et al (2018) Repeat reirradiation of the spinal cord: multi-national expert treatment recommendations. Strahlenther Onkol 194(5):365\u2013374","journal-title":"Strahlenther Onkol"},{"issue":"3","key":"1458_CR5","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s00066-017-1227-5","volume":"194","author":"S Dobiasch","year":"2018","unstructured":"Dobiasch S, Goerig NL, Fietkau R et\u00a0al (2018) Essential role of radiation therapy for the treatment of pancreatic cancer: novel study concepts and established treatment recommendations. Strahlenther Onkol 194(3):185\u2013195","journal-title":"Strahlenther Onkol"},{"key":"1458_CR6","volume-title":"Toxicities and outcomes using whole pleural intensity-modulated proton therapy. 8th international symposium on malignant pleural Mesothelioma","author":"CB Simone","year":"2018","unstructured":"Simone CB (2018) Toxicities and outcomes using whole pleural intensity-modulated proton therapy. 8th international symposium on malignant pleural Mesothelioma. UCLA, Los Angeles (29.9.2018)"},{"issue":"3","key":"1458_CR7","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/j.ijrobp.2009.09.053","volume":"77","author":"M Scorsetti","year":"2010","unstructured":"Scorsetti M, Bignardi M, Clivio A (2010) Volumetric modulation arc radiotherapy compared with static gantry intensity-modulated radiotherapy for malignant pleural mesothelioma tumor: a\u00a0feasibility study. Int J Radiat Oncol Biol Phys 77(3):942\u2013949","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"30","key":"1458_CR8","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1186\/s13014-015-0575-5","volume":"10","author":"C Thieke","year":"2015","unstructured":"Thieke C, Nicolay NH, Sterzing F (2015) Long-term results in malignant pleural mesothelioma treated with neoadjuvant chemotherapy, extrapleural pneumonectomy and intensity-modulated radiotherapy. Radiat Oncol 10(30):267","journal-title":"Radiat Oncol"},{"issue":"2","key":"1458_CR9","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1269\/jrr.11130","volume":"53","author":"T Ebara","year":"2012","unstructured":"Ebara T, Kawamura H, Kaminuma T et al (2012) Hemithoracic intensity-modulated radiotherapy using helical tomotherapy for patients after extrapleural pneumonectomy for malignant pleural mesothelioma. J\u00a0Radiat Res 53(2):288\u2013294","journal-title":"J Radiat Res"},{"key":"1458_CR10","first-page":"1","volume":"10","author":"ICRU. International Commission on Radiation Units and Measurements","year":"2010","unstructured":"ICRU. International Commission on Radiation Units and Measurements (2010) Prescribing, recording, and reporting photon-beam intensity-modulated radiation therapy (IMRT). ICRU Report 83. J ICRU 10:1\u2013106","journal-title":"J. ICRU"},{"issue":"4","key":"1458_CR11","first-page":"457","volume":"1","author":"A Rimner","year":"2012","unstructured":"Rimner A, Rosenzweig KE (2012) Novel radiation therapy approaches in malignant pleural mesothelioma. Ann Cardiothorac Surg 1(4):457\u2013461","journal-title":"Ann Cardiothorac Surg"},{"issue":"4","key":"1458_CR12","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1016\/j.ijrobp.2011.09.027","volume":"15;83","author":"KE Rosenzweig","year":"2012","unstructured":"Rosenzweig KE, Zauderer MG, Laser B et al (2012) Pleural intensity-modulated radiotherapy for malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys 15;83(4):1278\u20131283","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"1458_CR13","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s00066-017-1108-y","volume":"193","author":"A Botticella","year":"2017","unstructured":"Botticella A, Defraene G, Nackaerts K et\u00a0al (2017) Does selective pleural irradiation of malignant pleural mesothelioma allow radiation dose escalation?: a planning study. Strahlenther Onkol 193(4):285\u2013294","journal-title":"Strahlenther Onkol"},{"issue":"1","key":"1458_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.radonc.2017.08.003","volume":"125","author":"M Ashton","year":"2017","unstructured":"Ashton M, O\u2019Rourke N, Currie S et\u00a0al (2017) The role of radical radiotherapy in the management of malignant pleural mesothelioma: a systematic review. Radiother Oncol 125(1):1\u201312","journal-title":"Radiother Oncol"},{"issue":"1","key":"1458_CR15","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.lungcan.2013.10.013","volume":"83","author":"E Minatel","year":"2014","unstructured":"Minatel E, Trovo M, Polesel J et al (2014) Radical pleurectomy\/decortication followed by high dose of radiation therapy for malignant pleural mesothelioma. Final results with long-term follow-up. Lung Cancer 83(1):78\u201382","journal-title":"Lung Cancer"},{"issue":"5","key":"1458_CR16","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.rpor.2017.07.006","volume":"22","author":"S Harrabi","year":"2017","unstructured":"Harrabi S, Koerber S, Adeberg S et\u00a0al (2017) Malignant pleural mesothelioma\u2014pleural cavity irradiation after decortication with helical tomotherapy. Rep Pract Oncol Radiother 22(5):402\u2013407","journal-title":"Rep Pract Oncol Radiother"},{"issue":"12","key":"1458_CR17","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1097\/JTO.0b013e318272601f","volume":"7","author":"E Minatel","year":"2012","unstructured":"Minatel E, Trovo M, Polesel J et\u00a0al (2012) Tomotherapy after pleurectomy\/decortication or biopsy for malignant pleural mesothelioma allows the delivery of high dose of radiation in patients with intact lung. J\u00a0Thorac Oncol 7(12):1862\u20131866","journal-title":"J Thorac Oncol"},{"issue":"11","key":"1458_CR18","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1007\/s00066-011-2234-6","volume":"187","author":"A Fodor","year":"2011","unstructured":"Fodor A, Fiorino C, Dell\u2019Oca I et al (2011) PET-guided dose escalation tomotherapy in malignant pleural mesothelioma. Strahlenther Onkol 187(11):736\u2013743","journal-title":"Strahlenther Onkol"},{"issue":"5","key":"1458_CR19","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1007\/s00066-018-1265-7","volume":"194","author":"C Leitzen","year":"2018","unstructured":"Leitzen C, Wilhelm-Buchstab T, M\u00fcdder T et al (2018) Patient positioning in head and neck cancer: Setup variations and safety margins in helical tomotherapy. Strahlenther Onkol 194(5):386\u2013391","journal-title":"Strahlenther Onkol"},{"issue":"3","key":"1458_CR20","first-page":"265","volume":"4","author":"Z Zhu","year":"2015","unstructured":"Zhu Z, Fu X (2015) The radiation techniques of tomotherapy & intensity-modulated radiation therapy applied to lung cancer. Transl Lung Cancer Res 4(3):265\u2013274","journal-title":"Transl Lung Cancer Res"},{"issue":"3 Suppl","key":"1458_CR21","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.ijrobp.2009.09.040","volume":"76","author":"SM Bentzen","year":"2010","unstructured":"Bentzen SM, Constine LS, Deasy JO, Eisbruch A et\u00a0al (2010) Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): an introduction to the scientific issues. Int J Radiat Oncol Biol Phys 76(3 Suppl):S3\u2013S9","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"1458_CR22","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s00066-015-0901-8","volume":"192","author":"A Maggio","year":"2016","unstructured":"Maggio A, Cutaia C, Di al Dia Aet (2016) Tomotherapy PET-guided dose escalation: a dosimetric feasibility study for patients with malignant pleural mesothelioma. Strahlenther Onkol 192(2):102\u2013108","journal-title":"Strahlenther Onkol"}],"container-title":["Strahlentherapie und Onkologie"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-019-01458-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00066-019-01458-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00066-019-01458-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,25]],"date-time":"2020-03-25T00:22:30Z","timestamp":1585095750000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00066-019-01458-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,26]]},"references-count":22,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["1458"],"URL":"https:\/\/doi.org\/10.1007\/s00066-019-01458-1","relation":{},"ISSN":["0179-7158","1439-099X"],"issn-type":[{"value":"0179-7158","type":"print"},{"value":"1439-099X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,26]]},"assertion":[{"value":"1 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical guidelines"}},{"value":"C.\u00a0Leitzen, T.\u00a0Wilhelm-Buchstab, S.\u00a0Stumpf, M.\u00a0Heimann, D.\u00a0Koch, C.\u00a0Schmeel, B.\u00a0Simon, S.\u00a0Vornholt, S.\u00a0Garbe, F.\u00a0R\u00f6hner, F.\u00a0Schoroth, H.H.\u00a0Schild, H.\u00a0Sch\u00fcller, and T.\u00a0M\u00fcdder declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The accompanying manuscript does not include studies on humans or animals.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical standards"}}]}}